Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Al Baqlani, Said Ali ^a   Sy, Bui Tien ^b,c,d   Ratsch, Boris A ^b   Al Naamani, Khalid ^e   Al Awaidy, Salah ^f   Al Busaidy, Suleiman ^a   Pauli, Georg ^b   Bock, C Thomas ^b  

^a Central Public Health Laboratory   (Oman)

^b ROBERT KOCH INSTITUTE   (Germany)

^c VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e MILITARY TECHNOLOGICAL COLLEGE   (Oman)

^f Office of the Undersecretary for Health Affairs Ministry of Health   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS POLYMERASE; LAMIVUDINE; TELBIVUDINE; UNCLASSIFIED DRUG; VIRUS ENZYME; HEPATITIS B VACCINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROENTEROLOGY; GENE; GENE MUTATION; GENOTYPE; HBSAG GENE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE C; HEPATITIS B VIRUS GENOTYPE D; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OMAN; PHYLOGENY; PROTEIN DOMAIN; SEQUENCE ANALYSIS; VIRUS MUTATION; ADOLESCENT; AMINO ACID SEQUENCE; BLOOD; GENETICS; HEPATITIS B, CHRONIC; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTATION; OMAN; REVERSE TRANSCRIPTASE INHIBITORS; YOUNG ADULT;

EID: 84901295611     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097759     Document Type: Article

References (57)

1. WHO (2013) Hepatitis B. Fact sheet No204.
2. Lok AS (2009) Hepatitis B: liver fibrosis and hepatocellular carcinoma. Gastroenterol Clin Biol 33: 911-915.
3. Lok AS, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50: 661-662.
4. Fung SK, Lok AS (2004) Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40: 790-792. (Pubitemid 39288110)
5. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, et al. (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309. (Pubitemid 39541275)
6. Deterding K, Constantinescu I, Nedelcu FD, Gervain J, Nemecek V, et al. (2008) Prevalence of HBV genotypes in Central and Eastern Europe. J Med Virol 80: 1707-1711.
7. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, et al. (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81: 67-74. (Pubitemid 30047907)
8. McMahon BJ (2009) The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 3: 334-342.
9. Degertekin B, Lok AS (2009) Update on viral hepatitis: 2008. Curr Opin Gastroenterol 25: 180-185.
10. Kao JH, Chen DS (2005) Hepatitis B vaccination: to boost or not to boost? Lancet 366: 1337-1338.
11. Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J (2002) Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123: 1848-1856. (Pubitemid 35408309)
12. Chang MH (2014) Prevention of hepatitis B virus infection and liver cancer. Recent Results Cancer Res 193: 75-95.
13. Shi YH (2012) Correlation between hepatitis B virus genotypes and clinical outcomes. Jpn J Infect Dis 65: 476-482.
14. Toan NL, Song le H, Kremsner PG, Duy DN, Binh VQ, et al. (2006) Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology 43: 1375-1384.
15. Brunetto MR, Marcellin P, Cherubini B, Yurdaydin C, Farci P, et al. (2013) Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype. J Hepatol.
16. Westland C, Delaney Wt, Yang H, Chen SS, Marcellin P, et al. (2003) Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1. Gastroenterology 125: 107-116.
17. Cooksley WG (2010) Do we need to determine viral genotype in treating chronic hepatitis B? J Viral Hepat 17: 601-610.
18. Cassidy A, Mossman S, Olivieri A, De Ridder M, Leroux-Roels G (2011) Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity. Expert Rev Vaccines 10: 1709-1715.
19. Kaminski G, Alnaqdy A, Al-Belushi I, Nograles J, Al-Dhahry SH (2006) Evidence of occult hepatitis B virus infection among Omani blood donors: a preliminary study. Med Princ Pract 15: 368-372. (Pubitemid 44186825)
20. Al Awaidy S, Abu-Elyazeed R, Al Hosani H, Al Mulla A, Al Busaiedy S, et al. (2006) Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect 52: 202-206. (Pubitemid 43291725)
21. Al Awaidy ST, Bawikar SP, Al Busaidy SS, Al Mahrouqi S, Al Baqlani S, et al. (2013) Progress toward Elimination of Hepatitis B Virus Transmission in Oman: Impact of Hepatitis B Vaccination. Am J Trop Med Hyg 89: 811-815.
22. Blitz L, Pujol FH, Swenson PD, Porto L, Atencio R, et al. (1998) Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J Clin Microbiol 36: 648-651. (Pubitemid 28093243)
23. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Molecular Biology and Evolution 28: 2731-2739.
24. Martin DP, Lemey P, Lott M, Moulton V, Posada D, et al. (2010) RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 26: 2462-2463.
25. Mayerat C, Mantegani A, Frei PC (1999) Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 6: 299-304. (Pubitemid 29343810)
26. Chu CJ, Lok AS (2002) Clinical significance of hepatitis B virus genotypes. Hepatology 35: 1274-1276.
27. Kao JH (2002) Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 17: 643-650.
28. Mohammadnejad L, Farajnia S, Parivar K, Naghili B, Yousefzadeh Kheirnagsh R (2012) Hepatitis B virus genotypes in eastern Azerbaijan, Northwest Iran. Arch Iran Med 15: 446-448.
29. Sallam TA, William Tong CY (2004) African links and hepatitis B virus genotypes in the Republic of Yemen. J Med Virol 73: 23-28. (Pubitemid 38429142)
30. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, et al. (2005) Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol 76: 318-326. (Pubitemid 40770886)
31. Sunbul M, Leblebicioglu H (2005) Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey. World J Gastroenterol 11: 1976-1980. (Pubitemid 40520995)
32. Saudy N, Sugauchi F, Tanaka Y, Suzuki S, Aal AA, et al. (2003) Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt. J Med Virol 70: 529-536. (Pubitemid 36734716)
33. Bahri O, Cheikh I, Hajji N, Djebbi A, Maamouri N, et al. (2006) Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol 78: 353-357. (Pubitemid 43327834)
34. Hannoun C, Krogsgaard K, Horal P, Lindh M, Interpred trial g (2002) Genotype mixtures of hepatitis B virus in patients treated with interferon. J Infect Dis 186: 752-759. (Pubitemid 35013426)
35. Yin J, Zhang H, Li C, Gao C, He Y, et al. (2008) Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis 29: 1685-1691.
36. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557.
37. Dunford L, Carr MJ, Dean J, Nguyen LT, Ta Thi TH, et al. (2012) A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS One 7: e39027.
38. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, et al. (1997) Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26: 495-499. (Pubitemid 27328332)
39. Locarnini SA, Yuen L (2010) Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antivir Ther 15: 451-461.
40. Teo CG, Locarnini SA (2010) Potential threat of drug-resistant and vaccine-escape HBV mutants to public health. Antivir Ther 15: 445-449.
41. Carman WF (1997) The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4 Suppl 1: 11-20.
42. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL (1999) Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30: 1312-1317.
43. Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, et al. (1995) Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13: 699-702.
44. Ma Q, Wang Y (2012) Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol 84: 198-206.
45. Locarnini S, McMillan J, Bartholomeusz A (2003) The hepatitis B virus and common mutants. Semin Liver Dis 23: 5-20. (Pubitemid 36254659)
46. Bock CT, Tillmann HL, Torresi J, Klempnauer J, Locarnini S, et al. (2002) Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology 122: 264-273. (Pubitemid 34116979)
47. Bartholomeusz A, Locarnini S (2001) Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype. Hepatology 34: 432-435. (Pubitemid 32702359)
48. Weber B (2005) Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32: 102-112.
49. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, et al. (1998) Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27: 213-222.
50. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, et al. (1995) Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345: 1406-1407.
51. Khedive A, Norouzi M, Ramezani F, Karimzadeh H, Alavian SM, et al. (2013) Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study. J Viral Hepat 20: 494-501.
52. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, et al. (1997) The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26: 1658-1666. (Pubitemid 27520038)
53. Zuckerman JN, Zuckerman AJ (2003) Mutations of the surface protein of hepatitis B virus. Antiviral Res 60: 75-78. (Pubitemid 37452449)
54. Torresi J (2002) The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol 25: 97-106.
55. Tujios SR, Lee WM (2013) Update in the management of chronic hepatitis B. Curr Opin Gastroenterol 29: 250-256.
56. European Association For The Study Of The L (2012) EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 57: 167-185.
57. Baxa DM, Thekdi AD, Golembieski A, Krishnan PV, Sharif O, et al. (2013) Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States. J Hepatol 58: 212-216.